APhA Foundation announces 2025 Incentive Grant recipients
The Incentive Grants for Practitioner Innovation in Pharmaceutical Care is the APhA Foundation's longest-running program.
Pharmacy
Cardinal Health unveils state-of-the art chemistry lab
The Chemistry Center includes nearly 26,000 square feet of lab space dedicated to innovation and quality assurance and will provide a comprehensive range of testing services.
HDA Research Foundation announces Karen J. Ribler Supply Chain Scholars
The Foundation also named appointments to Its board of directors.
Health Network One names Heyward Donigan as new CEO
Most recently, Donigan served as president and CEO of Rite Aid.
Navitus survey: 88% of Americans demand prescription drug pricing reform
The findings emphasize a growing demand for affordable medication and transparent pricing from pharmacy benefit managers (PBMs), a sector many Americans are unfamiliar with.
Aetna Better Health of Illinois introduces same-day pharmacy delivery to members
First Medicaid managed care organization in Illinois to offer this service.
Camber rolls out generic Xeloda
Capecitabine is a nucleoside metabolic inhibitor indicated for the treatment of several cancers.
Cardinal Health announces two strategic additions to its portfolio
Acquisition of a majority stake in GI Alliance as well as Advanced Diabetes Supply Group.
Wakefern names Sapp VP of Pharmacy and Wellness
Sapp, who brings nearly 20 years of retail pharmacy leadership experience to his new role, will provide guidance to Wakefern members that operate ShopRite Pharmacies in the ever-evolving pharmacy landscape.
GlobalData: Trump’s return sparks uncertainty for U.S. pharma and health care industries
Trump's return to the White House brings renewed uncertainty to the U.S. pharmaceutical and health care industries, with potential shifts in policies affecting millions.
ADA teaming with pharmaceutical suppliers to support the needs of people with diabetes
Association working with Abbott and Gentech.
HDA convenes supply chain experts and patient advocates to examine drug shortages solutions
HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions.
Study: Majority of GLP-1 users discontinue drug early
The survey of people between the ages of 21 and 75 found that more than three-quarters (78%) discussed lifestyle changes with their prescriber before receiving or when receiving a GLP-1 medication.